Antibody to Vedolizumab ELISA
Enzyme immunoassay for the quantitative and qualitative determination of free antibodies to Vedolizumab (Entyvio®) in serum and plasma.
The solid phase (MTP) is coated by the drug Vedolizumab. Due to the assay design this test only measures the free antibodies which are not bound to Vedolizumab. Results are expressed in AU (arbitrary units).
Reference: IG-BB116
Barcode: 8682754930356
Legal Status: CE-Mark
Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Related Documents
Instructions for Use IG-BB116 804.79 KB
Material Safety Data Sheet (MSDS) IG-BB116 268.29 KB
Quality Control Certificates
Quality Control Certificate Lot: BB116-210 305.67 KB
Quality Control Certificate Lot: BB116-209 315.77 KB
Quality Control Certificate Lot: BB116-208 307.86 KB
Quality Control Certificate Lot: BB116-207 307.26 KB
Quality Control Certificate Lot: BB116-206 312.07 KB
Quality Control Certificate Lot: BB116-205 317.66 KB
Quality Control Certificate Lot: BB116-204 322.87 KB
Quality Control Certificate Lot: BB116-203 76.72 KB
Quality Control Certificate Lot: BB116-202 76.66 KB
Quality Control Certificate Lot: BB116-107 63.87 KB
Entyvio® is a trademark of Takeda Pharmaceuticals Inc.
The Kit at a glance:
| Required Volume (µL) | 50 |
| Incubation Time (min) | 135 |
| Sample | Serum/Plasma |
| Package Size | 96 Tests |
| Results in | Qualitative&Quantitative(ng/mL) |
| Shelf Life (years) | 2 |